INS and Other metabolic disease: Consistent with previous research (Xin et al., 2014; Wang Y. et al., 2019), we found that HFD successfully induced mice obesity and related metabolic disorders, as indicated by increased fat deposition, insulin resistance, and hepatic steatosis.